Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 169 to 173 of 173 entries
Sorted by: Best Match Show Resources per page
Use of casein micelles to improve the solubility of hydrophobic pea proteins in aqueous solutions via low-temperature homogenization.

Journal of dairy science

Krentz A, García-Cano I, Ortega-Anaya J, Jiménez-Flores R.
PMID: 34656351
J Dairy Sci. 2022 Jan;105(1):22-31. doi: 10.3168/jds.2021-20902. Epub 2021 Oct 14.

The dairy industry struggles to maintain consumer attention in the midst of declining fluid milk sales. Current trends create an opportunity to incorporate plant-based proteins with milk to produce a high-protein, multisourced, functional food product. Plant-based proteins, such as...

Cite
Krentz A, García-Cano I, Ortega-Anaya J, et al. Use of casein micelles to improve the solubility of hydrophobic pea proteins in aqueous solutions via low-temperature homogenization. J Dairy Sci. 2021;105(1):22-31doi: 10.3168/jds.2021-20902.
Krentz, A., García-Cano, I., Ortega-Anaya, J., & Jiménez-Flores, R. (2022). Use of casein micelles to improve the solubility of hydrophobic pea proteins in aqueous solutions via low-temperature homogenization. Journal of dairy science, 105(1), 22-31. https://doi.org/10.3168/jds.2021-20902
Krentz, Abigail, et al. "Use of casein micelles to improve the solubility of hydrophobic pea proteins in aqueous solutions via low-temperature homogenization." Journal of dairy science vol. 105,1 (2022): 22-31. doi: https://doi.org/10.3168/jds.2021-20902
Krentz A, García-Cano I, Ortega-Anaya J, Jiménez-Flores R. Use of casein micelles to improve the solubility of hydrophobic pea proteins in aqueous solutions via low-temperature homogenization. J Dairy Sci. 2022 Jan;105(1):22-31. doi: 10.3168/jds.2021-20902. Epub 2021 Oct 14. PMID: 34656351.
Copy Download .nbib Format: NLM
Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection.

Nature immunology

Dowell AC, Butler MS, Jinks E, Tut G, Lancaster T, Sylla P, Begum J, Bruton R, Pearce H, Verma K, Logan N, Tyson G, Spalkova E, Margielewska-Davies S, Taylor GS, Syrimi E, Baawuah F, Beckmann J, Okike IO, Ahmad S, Garstang J, Brent AJ, Brent B, Ireland G, Aiano F, Amin-Chowdhury Z, Jones S, Borrow R, Linley E, Wright J, Azad R, Waiblinger D, Davis C, Thomson EC, Palmarini M, Willett BJ, Barclay WS, Poh J, Amirthalingam G, Brown KE, Ramsay ME, Zuo J, Moss P, Ladhani S.
PMID: 34937928
Nat Immunol. 2022 Jan;23(1):40-49. doi: 10.1038/s41590-021-01089-8. Epub 2021 Dec 22.

SARS-CoV-2 infection is generally mild or asymptomatic in children but a biological basis for this outcome is unclear. Here we compare antibody and cellular immunity in children (aged 3-11 years) and adults. Antibody responses against spike protein were high...

Cite
Dowell AC, Butler MS, Jinks E, et al. Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection. Nat Immunol. 2021;23(1):40-49doi: 10.1038/s41590-021-01089-8.
Dowell, A. C., Butler, M. S., Jinks, E., Tut, G., Lancaster, T., Sylla, P., Begum, J., Bruton, R., Pearce, H., Verma, K., Logan, N., Tyson, G., Spalkova, E., Margielewska-Davies, S., Taylor, G. S., Syrimi, E., Baawuah, F., Beckmann, J., Okike, I. O., Ahmad, S., Garstang, J., Brent, A. J., Brent, B., Ireland, G., Aiano, F., Amin-Chowdhury, Z., Jones, S., Borrow, R., Linley, E., Wright, J., Azad, R., Waiblinger, D., Davis, C., Thomson, E. C., Palmarini, M., Willett, B. J., Barclay, W. S., Poh, J., Amirthalingam, G., Brown, K. E., Ramsay, M. E., Zuo, J., Moss, P., & Ladhani, S. (2022). Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection. Nature immunology, 23(1), 40-49. https://doi.org/10.1038/s41590-021-01089-8
Dowell, Alexander C, et al. "Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection." Nature immunology vol. 23,1 (2022): 40-49. doi: https://doi.org/10.1038/s41590-021-01089-8
Dowell AC, Butler MS, Jinks E, Tut G, Lancaster T, Sylla P, Begum J, Bruton R, Pearce H, Verma K, Logan N, Tyson G, Spalkova E, Margielewska-Davies S, Taylor GS, Syrimi E, Baawuah F, Beckmann J, Okike IO, Ahmad S, Garstang J, Brent AJ, Brent B, Ireland G, Aiano F, Amin-Chowdhury Z, Jones S, Borrow R, Linley E, Wright J, Azad R, Waiblinger D, Davis C, Thomson EC, Palmarini M, Willett BJ, Barclay WS, Poh J, Amirthalingam G, Brown KE, Ramsay ME, Zuo J, Moss P, Ladhani S. Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection. Nat Immunol. 2022 Jan;23(1):40-49. doi: 10.1038/s41590-021-01089-8. Epub 2021 Dec 22. PMID: 34937928.
Copy Download .nbib Format: NLM
Stakeholders' Perceptions of a School-Based Eye Care Programme in Baltimore, MD.

Ophthalmic epidemiology

Kretz AM, Vongsachang H, Friedman DS, Callan J, Wahl M, Mukherjee MR, Neitzel A, Collins ME.
PMID: 34251966
Ophthalmic Epidemiol. 2021 Jul 12;1-10. doi: 10.1080/09286586.2021.1946825. Epub 2021 Jul 12.

PURPOSE: To explore stakeholders' perceptions of a school-based vision programme (SBVP).METHODS: We conducted 20 focus groups with 105 parents and teachers at schools in Baltimore, MD, that participated in a SBVP. Facilitators used a semi-structured interview guide to discuss...

Cite
Kretz AM, Vongsachang H, Friedman DS, et al. Stakeholders' Perceptions of a School-Based Eye Care Programme in Baltimore, MD. Ophthalmic Epidemiol. 2021;1-10doi: 10.1080/09286586.2021.1946825.
Kretz, A. M., Vongsachang, H., Friedman, D. S., Callan, J., Wahl, M., Mukherjee, M. R., Neitzel, A., & Collins, M. E. (2021). Stakeholders' Perceptions of a School-Based Eye Care Programme in Baltimore, MD. Ophthalmic epidemiology, 1-10. https://doi.org/10.1080/09286586.2021.1946825
Kretz, Alyssa M, et al. "Stakeholders' Perceptions of a School-Based Eye Care Programme in Baltimore, MD." Ophthalmic epidemiology vol. (2021): 1-10. doi: https://doi.org/10.1080/09286586.2021.1946825
Kretz AM, Vongsachang H, Friedman DS, Callan J, Wahl M, Mukherjee MR, Neitzel A, Collins ME. Stakeholders' Perceptions of a School-Based Eye Care Programme in Baltimore, MD. Ophthalmic Epidemiol. 2021 Jul 12;1-10. doi: 10.1080/09286586.2021.1946825. Epub 2021 Jul 12. PMID: 34251966.
Copy Download .nbib Format: NLM
The Novel, Orally Bioavailable CDK9 Inhibitor Atuveciclib Sensitises Pancreatic Cancer Cells to TRAIL-induced Cell Death.

Anticancer research

Ruff JP, Kretz AL, Kornmann M, Henne-Bruns D, Lemke J, Traub B.
PMID: 34848451
Anticancer Res. 2021 Dec;41(12):5973-5985. doi: 10.21873/anticanres.15416.

BACKGROUND/AIM: This study was designed to analyse the effects of the novel, orally bioavailable CDK9-inhibitor Atuveciclib (BAY 1143572) in combination with tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) on pancreatic ductal adenocarcinoma (PDAC) cancer cells.MATERIALS AND METHODS: To assess the...

Cite
Ruff JP, Kretz AL, Kornmann M, et al. The Novel, Orally Bioavailable CDK9 Inhibitor Atuveciclib Sensitises Pancreatic Cancer Cells to TRAIL-induced Cell Death. Anticancer Res. 2021;41(12):5973-5985doi: 10.21873/anticanres.15416.
Ruff, J. P., Kretz, A. L., Kornmann, M., Henne-Bruns, D., Lemke, J., & Traub, B. (2021). The Novel, Orally Bioavailable CDK9 Inhibitor Atuveciclib Sensitises Pancreatic Cancer Cells to TRAIL-induced Cell Death. Anticancer research, 41(12), 5973-5985. https://doi.org/10.21873/anticanres.15416
Ruff, Jan-Philipp, et al. "The Novel, Orally Bioavailable CDK9 Inhibitor Atuveciclib Sensitises Pancreatic Cancer Cells to TRAIL-induced Cell Death." Anticancer research vol. 41,12 (2021): 5973-5985. doi: https://doi.org/10.21873/anticanres.15416
Ruff JP, Kretz AL, Kornmann M, Henne-Bruns D, Lemke J, Traub B. The Novel, Orally Bioavailable CDK9 Inhibitor Atuveciclib Sensitises Pancreatic Cancer Cells to TRAIL-induced Cell Death. Anticancer Res. 2021 Dec;41(12):5973-5985. doi: 10.21873/anticanres.15416. PMID: 34848451.
Copy Download .nbib Format: NLM
Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection.

Nature immunology

Dowell AC, Butler MS, Jinks E, Tut G, Lancaster T, Sylla P, Begum J, Bruton R, Pearce H, Verma K, Logan N, Tyson G, Spalkova E, Margielewska-Davies S, Taylor GS, Syrimi E, Baawuah F, Beckmann J, Okike IO, Ahmad S, Garstang J, Brent AJ, Brent B, Ireland G, Aiano F, Amin-Chowdhury Z, Jones S, Borrow R, Linley E, Wright J, Azad R, Waiblinger D, Davis C, Thomson EC, Palmarini M, Willett BJ, Barclay WS, Poh J, Amirthalingam G, Brown KE, Ramsay ME, Zuo J, Moss P, Ladhani S.
PMID: 34937928
Nat Immunol. 2022 Jan;23(1):40-49. doi: 10.1038/s41590-021-01089-8. Epub 2021 Dec 22.

SARS-CoV-2 infection is generally mild or asymptomatic in children but a biological basis for this outcome is unclear. Here we compare antibody and cellular immunity in children (aged 3-11 years) and adults. Antibody responses against spike protein were high...

Cite
Dowell AC, Butler MS, Jinks E, et al. Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection. Nat Immunol. 2021;23(1):40-49doi: 10.1038/s41590-021-01089-8.
Dowell, A. C., Butler, M. S., Jinks, E., Tut, G., Lancaster, T., Sylla, P., Begum, J., Bruton, R., Pearce, H., Verma, K., Logan, N., Tyson, G., Spalkova, E., Margielewska-Davies, S., Taylor, G. S., Syrimi, E., Baawuah, F., Beckmann, J., Okike, I. O., Ahmad, S., Garstang, J., Brent, A. J., Brent, B., Ireland, G., Aiano, F., Amin-Chowdhury, Z., Jones, S., Borrow, R., Linley, E., Wright, J., Azad, R., Waiblinger, D., Davis, C., Thomson, E. C., Palmarini, M., Willett, B. J., Barclay, W. S., Poh, J., Amirthalingam, G., Brown, K. E., Ramsay, M. E., Zuo, J., Moss, P., & Ladhani, S. (2022). Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection. Nature immunology, 23(1), 40-49. https://doi.org/10.1038/s41590-021-01089-8
Dowell, Alexander C, et al. "Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection." Nature immunology vol. 23,1 (2022): 40-49. doi: https://doi.org/10.1038/s41590-021-01089-8
Dowell AC, Butler MS, Jinks E, Tut G, Lancaster T, Sylla P, Begum J, Bruton R, Pearce H, Verma K, Logan N, Tyson G, Spalkova E, Margielewska-Davies S, Taylor GS, Syrimi E, Baawuah F, Beckmann J, Okike IO, Ahmad S, Garstang J, Brent AJ, Brent B, Ireland G, Aiano F, Amin-Chowdhury Z, Jones S, Borrow R, Linley E, Wright J, Azad R, Waiblinger D, Davis C, Thomson EC, Palmarini M, Willett BJ, Barclay WS, Poh J, Amirthalingam G, Brown KE, Ramsay ME, Zuo J, Moss P, Ladhani S. Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection. Nat Immunol. 2022 Jan;23(1):40-49. doi: 10.1038/s41590-021-01089-8. Epub 2021 Dec 22. PMID: 34937928; PMCID: PMC8709786.
Copy Download .nbib Format: NLM
Showing 169 to 173 of 173 entries